Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof

A technology of Bacillus licheniformis and prebiotics, which is applied in the field of medicine and biology to achieve the effects of inhibiting growth, improving immunity and reducing diarrhea

Active Publication Date: 2009-09-23
SHENYANG NO 1 PHARMA FACTORY DONGBEI PHARMA GRP
View PDF0 Cites 36 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Oligosaccharides are an important class of prebiotics. The current research is mainly on probiotics such as bifidobacteria and lactic acid bacteria. They have a highly selective proliferation effect on probiotics, greatly impr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof
  • Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030]Get Bacillus licheniformis live bacteria powder 30Kg (contain live bacteria 30 billion in every gram of live bacteria powder, the same below), xylo-oligosaccharide 120Kg, microcrystalline cellulose 150Kg, starch 25Kg, low-substituted hydroxypropyl cellulose 17.5Kg, Grinding through a 80 mesh sieve and mixing evenly, adding 5% povidone K30 to make soft materials in an appropriate amount, making wet granules through a 20 mesh sieve, drying at 40°C, sizing through a 18 mesh sieve, adding 1.5Kg of magnesium stearate, mixing evenly, pressing The tablet is packaged and obtained, and each gram of the composition contains 1 billion bacillus licheniformis.

Embodiment 2

[0032] Take 30Kg of live Bacillus licheniformis powder, 150Kg of xylooligosaccharides, 75Kg of dextrin, 70Kg of starch, and 14Kg of sodium carboxymethyl starch, grind them through an 80-mesh sieve and mix them evenly, add 4% hydroxypropyl methylcellulose in an appropriate amount to make soft material, wet granules with 20 mesh sieve, dry at 40°C, granulate with 18 mesh sieve, add 3.5Kg of talcum powder, mix evenly, compress into tablets, and pack to obtain. Each gram of composition contains 1.021 billion Bacillus licheniformis.

Embodiment 3

[0034] Take 30Kg of live Bacillus licheniformis powder, 120Kg of xylo-oligosaccharide, 120Kg of pregelatinized starch, 65Kg of microcrystalline cellulose, 14Kg of crospovidone, pulverize and pass through an 80-mesh sieve and mix evenly, add 1.5Kg of magnesium stearate, After mixing evenly, it is directly compressed into tablets and packaged to obtain the product. Each gram of the composition contains 1.086 billion bacillus licheniformis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and a composite and a formulation thereof, being characterized in that the synbiotics comprises bacillus licheniformis medical live bacterial powder and the oligosaccharide class prebiotics, wherein the bacillus licheniformis medical live bacterial powder contains live bacteria about 30 billion/gram; the weight ratio of the bacillus licheniformis medical live bacterial powder to the oligosaccharide class prebiotics is 1:1 to 76; the weight ratio of the medical live bacterial powder of the composite, the oligosaccharide class prebiotics and auxiliary materials is as follows: 1.25-5 percent of the bacillus licheniformis medical live bacterial powder, 5-95 percent of the oligosaccharide class prebiotics, 20-50 percent of preferable oligosaccharide class prebiotics, 30-65 percent of diluting agents, 1-20 percent of bonding agents, 1-15 percent of disintegrating agents, 0.1-3 percent of lubricating agents, 1-10 percent of coating agents, 0.01-0.1 percent of flavoring agents, 0.0001-0.001 percent of coloring agents, and 0.1-15 percent of suspending agents. The synbiotics composite is prepared into oral common tablets, oral cavity disintegration tablets, dispersing tablets, enteric-coated tablets, granular formulation, enteric-coated granular formulation, capsules, enteric-coated capsules, dry supensoid agents and external tablets according to a conventional process; and an in vitro test shows that each formulation can promote the growth and the reproduction of the synbiotics of bacillus licheniformis, restrain the growth of harmful bacteria, enhance the immunizing power of parasitifers, reduce diarrhea and enhance the health care.

Description

Technical field [0001] The invention belongs to the field of medical biotechnology and relates to a synbiotic of Bacillus licheniformis and oligosaccharide prebiotics and its composition and preparation. Background technique [0002] With the deepening of microecology, microecological modulators have also developed rapidly. The so-called microecological modulator refers to the adjustment of microecological imbalance, maintenance of microecological balance, and improvement of microecological balance under the guidance of microecological theory. Preparations made of beneficial bacteria and their metabolites and growth-promoting substances that improve human health or enhance health, also known as microbial products. It is a new type of preparations developed after antibiotics that contain beneficial microorganisms and their growth-promoting substances. . Unlike antibiotics, these products do not kill bacteria, but promote bacteria, promoting the growth and development of phys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/74A61P37/04A61P1/12A61P1/14A61K31/702A61K35/742
Inventor 郑白水李显林苏显英李雪龙崔苛
Owner SHENYANG NO 1 PHARMA FACTORY DONGBEI PHARMA GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products